1. Home
  2. ALOT vs CRVO Comparison

ALOT vs CRVO Comparison

Compare ALOT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • CRVO
  • Stock Information
  • Founded
  • ALOT 1969
  • CRVO 2001
  • Country
  • ALOT United States
  • CRVO United States
  • Employees
  • ALOT N/A
  • CRVO N/A
  • Industry
  • ALOT Computer peripheral equipment
  • CRVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALOT Technology
  • CRVO Health Care
  • Exchange
  • ALOT Nasdaq
  • CRVO Nasdaq
  • Market Cap
  • ALOT 78.2M
  • CRVO 67.4M
  • IPO Year
  • ALOT N/A
  • CRVO N/A
  • Fundamental
  • Price
  • ALOT $9.83
  • CRVO $8.70
  • Analyst Decision
  • ALOT
  • CRVO Strong Buy
  • Analyst Count
  • ALOT 0
  • CRVO 6
  • Target Price
  • ALOT N/A
  • CRVO $19.17
  • AVG Volume (30 Days)
  • ALOT 28.9K
  • CRVO 97.2K
  • Earning Date
  • ALOT 09-09-2025
  • CRVO 11-11-2025
  • Dividend Yield
  • ALOT N/A
  • CRVO N/A
  • EPS Growth
  • ALOT N/A
  • CRVO N/A
  • EPS
  • ALOT N/A
  • CRVO N/A
  • Revenue
  • ALOT $151,593,000.00
  • CRVO $7,776,968.00
  • Revenue This Year
  • ALOT N/A
  • CRVO N/A
  • Revenue Next Year
  • ALOT N/A
  • CRVO N/A
  • P/E Ratio
  • ALOT N/A
  • CRVO N/A
  • Revenue Growth
  • ALOT 0.63
  • CRVO N/A
  • 52 Week Low
  • ALOT $7.53
  • CRVO $1.80
  • 52 Week High
  • ALOT $17.24
  • CRVO $16.94
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 39.67
  • CRVO 51.64
  • Support Level
  • ALOT $9.88
  • CRVO $7.90
  • Resistance Level
  • ALOT $10.48
  • CRVO $8.37
  • Average True Range (ATR)
  • ALOT 0.34
  • CRVO 0.44
  • MACD
  • ALOT 0.02
  • CRVO 0.03
  • Stochastic Oscillator
  • ALOT 20.39
  • CRVO 80.99

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: